GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models. Gorgogietas V, Rajaei B, Heeyoung C, Santacreu BJ, et al. Diabetologia 2023;66:1306-1321.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gorgogietas V, Rajaei B, Heeyoung C, Santacreu BJ, et al. GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models. Diabetologia 2023;66:1306-1321.
PMID: 36995380